The great explorer of the truth, the master-builder of human happiness no one rejects dislikes avoids pleasure itself because it is pleasure but because know who do not those how to pursue pleasures rationally encounter consequences that are extremely painful desires to obtain.Read More
Europe Intragastric Balloon Market Size to Outpace USD 40 Mn By 2026
Published Date: 2020-02-19
Request a sample
According to the Graphical Research new growth forecast report titled Europe Intragastric Balloon Market Value By End-use (Hospitals, Ambulatory Surgical Centers, Clinics), By Product (Single Intragastric Balloon, Dual Intragastric Balloon, Triple Intragastric Balloon), By Filling Material (Saline-filled Balloon, Gas-filled Balloon), Industry Analysis Report, Regional Outlook Germany, UK, France, Spain, Italy, Belgium, The Netherlands, Poland, Portugal, Russia, Sweden, Switzerland, Turkey”, Estimated To Exceed USD 40 Million By 2026.
Increased incidence of obesity will drive the demand for intragastric balloons. Intragastric balloons treat obesity by limiting the patient’s food intake, resulting in weight loss. According to Organisation for Economic Co-operation and Development (OECD) statistics, in 2017, about 35% of the population in the UK were obese. The number is expected to increase due to sedentary lifestyle and consumption of junk food. Thus, as the number of obese individuals increases, it will drive the demand for intragastric balloons over the forecast period.
Rising demand for minimally invasive techniques will propel the European intragastric balloon market. Intragastric balloons offer a non-surgical treatment for obesity. Other procedures such as gastric bypass and gastrectomy involve complicated surgical procedures. Minimally invasive techniques are preferred by patients due to advantages such as limited blood loss, reduced hospital stay and faster recovery. These factors will drive the demand for intragastric balloons, propelling the market expansion.
However, complications and risks related to intragastric balloon procedure will dampen the market expansion. Furthermore, lack of reimbursement for the procedure will impede the market growth in the future.
The market is segmented into single balloon, dual balloon, and triple balloon by product. The dual balloon segment will exhibit nearly 30% CAGR over the forecast period and will be the fastest growing segment. Dual intragastric balloons expedite the weight loss procedure in a limited timeframe due to presence of two connected balloons. They also reduce the risk of migration and increase patient comfort. These factors will spur the segment growth, boosting the industry expansion.
Intragastric balloons by filling material are bifurcated into saline-filled and gas-filled balloons. The gas-filled balloon segment held about 36% market share in 2019 and will witness substantial growth over the forecast period. Advantages such as gastric acid resistance, bacteria resistance and the light weight of the balloon will drive the product demand. Additionally, these balloons increase patient compliance during removal and are resistant to spontaneous deflation. These factors will boost the segment growth over the analysis timeframe.
Germany led the European intragastric balloon market by share and will exhibit a robust CAGR over the forecast timeframe. According to WHO, about 25.1% of the German population was obese in 2013 and Germany is the second most obese nation in Europe. Furthermore, obesity rates are expected to rise due to factors such as a sedentary lifestyle and preference for junk food. This will propel the demand for intragastric balloons in the country. Also, high rate of technology adoption in the country will boost the preference for novel therapeutic products such as intragastric balloons. These factors will positively impact the German intragastric balloon market.
Key market players in Europe intragastric balloon market are Allurion Technologies, Apollo Endosurgery Inc., Halex Istar Industria Farmaceutica Ltd., Helioscopie Medical Implants, Obalon Therapeutics Inc., and Reshape Lifesciences Inc. These companies are focusing on strategies such as new product launches, and mergers to consolidate their market share and customer base. For instance, in December 2015, Allurion Technologies received the CE mark for its Eclipse gastric balloon. This has allowed the company to sell its product in the European union, expanding its customer base and strengthening its market position.
Europe Medical Intragastric Balloon Market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2015 to 2026, for the following segments:
Europe Intragastric Balloon Market Share, By Product, 2015 to 2026, (USD Million)
- Single Balloon
- Dual Balloon
- Triple Balloon
Europe Intragastric Balloon Market Size, By Filling Material, 2015 to 2026, (USD Million)
- Saline Solution
Europe Intragastric Balloon Market Value, By End-use, 2015 to 2026, (USD Million)
- Ambulatory Surgical Centers
The above information is provided for the following region and countries: